ARMS inks 5-year exclusive partnership for DermaPure®
ARMS Medical/Tissue Regenix to exhibit at SUFU 2018 regional meeting
AUGS publishes best practice statement on pelvic organ prolapse
DermaPure demonstrates significant cost savings and clinical benefits to healthcare providers
FDA reclassifies vaginal mesh, device used for prolapse, as ‘high risk’
Mesh News highlights for 2017 revisited
NHS England puts an immediate curb on mesh operations after safety concerns
Surgical smoke nearly killed me
Tissue Regenix launches new unit as it inks US distribution deal
Copyright © 2024 ARMS
Medical. All Rights Reserved.